28 reports

  • latanoprostene bunod
  • Company Analysis and Positioning

Aerie Pharmaceuticals.

  • Eye Disease
  • Health Services
  • Ophthalmology
  • Pharmaceutical
  • Shionogi & Co., Ltd.
  • 8.1 References
  • 4.6.9 Conclusion

This highlights pharmaceutical companies' interest in investment in analgesics.

  • Analgesic
  • Opioid
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.
  • Cancer Supportive Care Market, Global, Cluster by Growth and Market Share, 2015-
  • Cancer Supportive Care Market, Global, Company Analysis Matrix, 2015-2022

Spectrum Pharmaceuticals.

  • Blood Disease
  • Cancer
  • Pathology
  • Pharmaceutical
  • Shionogi & Co., Ltd.
  • Top 10 pharmaceutical Companies: Revenue
  • Top 10 pharmaceutical Companies: Shionogi
  • Pharmaceutical
  • Alfresa Group
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company
  • Shionogi & Co., Ltd.
  • 10.1 OVERVIEW
  • PRODUCT PROFILE - DORIBAX

REMPEX PHARMACEUTICALS INC.

  • Pharmaceutical
  • Company
  • Demand
  • Market Size
  • Shionogi & Co., Ltd.
  • OIC - LATE-STAGE PIPELINE, 2015
  • Executive Summary

Pharma, press release, May ##, 2012).

  • Gastrointestinal Drug
  • Opioid
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.
  • Pfizer
  • Vendor landscape
  • Hormone
  • Pharmaceutical
  • Therapy
  • Market Size
  • Shionogi & Co., Ltd.

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2015.

  • Advertising
  • Computer
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA RETAIL BRANDS' ONLINE ADVERTISING SPEND - SPLIT BY MOBILE AND DESKTOP (US$ MILLION), 2015 VS. 2020 ##. ## Pharmaceutical & Healthcare Online Ad Spend Being among the few countries that allow direct to consumer marketing of pharmaceutical products, digital ad

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2014.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd
  • LATE-STAGE PIPELINE FOR AR, 2014
  • 7 Pipeline Assessment

THE DRUG WAS ORIGINALLY DEVELOPED BY A PRIVATE PHARMACEUTICAL COMPANY TAIHO PHARMACEUTICALS.

  • Allergy Drug
  • Pharmaceutical
  • Therapy
  • Forecast
  • Shionogi & Co., Ltd.
  • LATE-STAGE PIPELINE FOR AR, 2014
  • 7 Pipeline Assessment

THE DRUG WAS ORIGINALLY DEVELOPED BY A PRIVATE PHARMACEUTICAL COMPANY TAIHO PHARMACEUTICALS.

  • Pharmaceutical
  • Therapy
  • United States
  • Forecast
  • Shionogi & Co., Ltd.
  • LATE-STAGE PIPELINE FOR AR, 2014
  • 7 Pipeline Assessment

THE DRUG WAS ORIGINALLY DEVELOPED BY A PRIVATE PHARMACEUTICAL COMPANY TAIHO PHARMACEUTICALS.

  • Allergy Drug
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.
  • Shionogi & Co., Ltd.

FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2010-2019 ##. ##. ## SNAPSHOT, 2010-2019 FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND - BREAKDOWN BY MARKETING OBJECTIVE (%), 2014VS. 2019 Bran

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • CLINICAL AND COMMERCIAL ATTRACTIVENESS
  • MECHANICAL VENTILATION IS RARELY USED IN THE UK

Pharmaceuticals Policy and Law, ##, ##-##.

  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Boehringer Ingelheim GmbH
  • Shionogi & Co., Ltd.
  • SHIONOGI & CO LTD, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • SHIONOGI & CO LTD, PHARMACEUTICALS & HEALTHCARE, DEALS BY REGION, 2011 TO YTD 2017
  • Pharmaceutical
  • Japan
  • United States
  • Company Financials
  • Shionogi & Co., Ltd.
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • SHIONOGI INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2011 TO YTD 2017
  • Pharmaceutical
  • United States
  • Company
  • M&A
  • Shionogi & Co., Ltd.
  • Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Healthcare
  • Pharmaceutical
  • Japan
  • Company Financials
  • Shionogi & Co., Ltd.
  • TARGET: SCIELE PHARMA, INC.
  • PARTNER 2: SCIELE PHARMA, INC.
  • Pharmaceutical
  • Japan
  • United States
  • Company
  • Shionogi & Co., Ltd.
  • SHIONOGI & CO., LTD.: KEY COMPETITORS
  • SHIONOGI & CO., LTD.: MANAGEMENT STATEMENT
  • Pharmaceutical
  • Therapy
  • Japan
  • Company
  • Shionogi & Co., Ltd.
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deal Details
  • Concordia Pharma And Shionogi Enter Into Licensing Agreement For Ulesfia
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Shionogi & Co., Ltd.
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deal Details
  • Concordia Pharma And Shionogi Enter Into Licensing Agreement For Ulesfia
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Shionogi & Co., Ltd.
  • Valuation multiples (C&O Pharmaceutical Technology (Holdings) Limited)
  • PRIVATE EQUITY AND OWNERSHIP - DEAL REPORTS
  • Pharmaceutical
  • China
  • United Kingdom
  • M&A
  • Shionogi & Co., Ltd.
  • SHIONOGI & CO LTD OVERVIEW
  • Shionogi & Co Ltd, Key Facts

AND PURDUE PHARMA L. P.

  • Pharmaceutical
  • Japan
  • World
  • Product Initiative
  • Shionogi & Co., Ltd.
  • Sales Comparisons (Most Recent Fiscal Year)
  • Summary of company valuations (as of 10/6/2017).

Ltd. is a Japan-based pharmaceutical company.

  • Pharmaceutical
  • Japan
  • Company Financials
  • Shionogi & Co., Ltd.
  • SHIONOGI & CO., LTD.: KEY COMPETITORS
  • SHIONOGI & CO., LTD.: MANAGEMENT STATEMENT
  • Pharmaceutical
  • Therapy
  • Japan
  • Company
  • Shionogi & Co., Ltd.
  • OF CONTENTS
  • PARTNERSHIP - DEAL REPORTS
  • Pharmaceutical
  • United Kingdom
  • Company
  • Company Financials
  • Shionogi & Co., Ltd.
  • DEAL IN BRIEF
  • DEAL IN BRIEF
  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Shionogi & Co., Ltd.